TREATMENT RESISTANT DEPRESSION

What happens when traditional treatments for depression fail to provide relief? This is the reality faced by individuals with treatment resistant depression (TRD). Despite multiple attempts with various therapies, some individuals continue to experience persistent depressive symptoms. TRD poses significant challenges and requires a different approach to find effective solutions. In this article, we will explore the complexities of treatment-resistant depression and delve into potential strategies that can offer hope and improved outcomes for those affected.

Symptoms of Depression Include:

• Feeling irritable and un-focused
• Feeling empty and alone.
• Loss of interest in every activities.
• Loss of pleasure most days, nearly every day, or for at least two weeks.
• Feelings of hopelessness, guilt, and of virtually no self-worth.
• Thoughts of suicide.
• Disruptive sleep.
• Loss of appetite, weakness, pain, and fatigue.
• Difficulty socializing.

5 Major Groups of Antidepressants

Although, there have been proven and effective oral antidepressants to treat depression, not everyone responds to these drugs. There are five major groups of antidepressants.

1. Selective serotonin reuptake inhibitors (SSRIs)- Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants. They are known to cause the least number of side effects. Some examples would be Fluoxetine (Prozac), Cipralex, Cipramil, Seroxat, and Lustral.
2. Seratonin-noradrenaline reuptake inhibitors (SNRIs)- Serotonin-noradrenaline reuptake inhibitors (SNRIs) are similar to SSRIs but designed to be more effective. The jury is still out on their efficacy. Some examples would be Cymbalta.
3. Noradrenaline and specific serotonergic antidepressants (NASSAs)- Noradrenaline and specific serotonergic antidepressants (NASSAs) were designed for individuals who were unable to take SSRIs. They were thought to cause fewer sexual problems; however, they were likely to induce more drowsiness at the beginning of treatment. An example Zispin.
4. Tricyclic antidepressants (TCAs)- Tricyclic antidepressants (TCAs) are a somewhat outdated type of antidepressant. The side effects are more severe and can be quite dangerous in case of an overdose. They often lead to weight gain and are not frequently prescribed. Additionally, they are used off-label to treat chronic nerve pain. An example would be amitriptyline.

The last two types are Monoamine oxidase inhibitors (MAOIs) and Serotonin antagonists and reuptake inhibitors (SARIs). These older antidepressants also tend to cause weight gain and are not usually the first choice of treatment.

Other Types of Medications

There are often other types of medications that physicians will try to assist with mood disorders. Mood stabilisers, such as lithium, act to block the serotonin “transporter” protein. This protein typically clears away serotonin at the synapse between the sending and receiving cells. However, by blocking the transporter, the excess serotonin can be absorbed by the receiving cell. Lithium is now seldom prescribed because of its toxic effects on the thyroid gland and kidneys. Other medications have taken its place for the management of bipolar disorders.

Explanation:

There are many drugs proven to successfully treat depression, but unfortunately not everyone responds to all of them.

Typically, treatment resistant depression (TRD) refers to individuals who have not responded adequately to at least two different antidepressants from two different classes or groups. Often, at this point, many psychiatrists will attempt a combination of oral antidepressant medications to work together. If this doesn’t work, these individuals are often left feeling helpless, as if they will never escape the internal turmoil they experience.

To ensure that oral antidepressant medications have been given a fair trial, they must be taken for 6 to 8 weeks before they fully take effect. Skipping doses will interfere with the effectiveness of the drug. However, many people can experience unpleasant side effects with some of the prescribed antidepressants, making it impossible to continue with the medication.

Treatment-resistant depression is a relatively common finding in patients with depression. This psychiatric disorder can be seen in 50-60 percent of patients who are unable to achieve an adequate response to antidepressant treatment. So where do these individuals suffering from this severe depression go from there?

Due to such an inadequate response to typical treatments, fortunately, groundbreaking therapies have been researched and discovered over the years, with their main focus being on treatment-resistant depression. Exploring the Evidence-Based Benefits of Psychedelic-Assisted Therapy for Depression.

Psychedelic Assisted Therapy

Psychedelic-assisted therapy (PAT) is an emerging treatment option for major depressive disorder (MDD), and recent clinical trials have yielded promising results. However, the mechanisms underlying the antidepressant effects of psychedelics remain poorly understood. Here, we review evidence from experimental animal models and human clinical studies, suggesting that psychedelic-assisted therapy may exert its antidepressant effects, in part, by modulating serotonin neurotransmission and associated neural circuits.

Serotonergic Modulation

It is depression associated alterations in brain network connectivity. Major depressive disorder (MDD) is characterized by disturbances in emotion, cognition, and behavior that arise from abnormalities in large-scale brain systems. Although serotonin neurotransmission has long been implicated in the pathophysiology of major depressive disorders, the effects of serotonin on distributed neural circuitry underlying emergent mental states are not well understood. Here, we review evidence from experimental animal models and human clinical studies suggesting that serotonin may exert its antidepressant effects, in part, by modulating the activity of distributed brain networks.

Rapid Acting Antidepressants

Rapid-acting antidepressants can be taken soon after feeling depressed and provide a fast effect. Many new compounds have been developed to treat depression, but none are used as antidepressants in clinical practice. Most of these compounds target specific pathways that affect mood, like serotonin reuptake inhibitors (SRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), and various norepinephrine and dopamine receptor blockers.

One studied compound is memantine, which helps treat resistant depression. It is generally well tolerated and produces quick results. Ketamine, a few other NMDA receptor blockers, and scopolamine have shown rapid antidepressant effects in controlled studies. Psychedelic drugs have limited available data but seem to affect AMPA receptors. While ketamine’s effects are limited, psychedelic drugs can have long-lasting effects for months.

Pros and Cons of Using Ketamine, MDMA, LSD, and Psilocybin

Depression is a major problem worldwide, and treatment-resistant depression (TRD) poses a significant challenge for clinicians. A number of new strategies are being developed to treat treatment-resistant depression, including the use of psychedelics. Psychedelics have shown promise in treating depression, but there are also potential risks associated with their use. This review examines the literature on the efficacy of ketamine, MDMA, LSD, and psilocybin in treating depression, as well as the risks associated with their use.

Ketamine-resistant depression (KrD)

It is a treatment-resistant form of depression that is unresponsive to standard antidepressant therapies. Ketamine-resistant depression has been associated with negative side effects, including dissociative symptoms and suicidal thoughts. Several clinical trials have examined the efficacy of ketamine in treating depression, and the results have been mixed. Some studies have found that ketamine is effective in treating depression, while others have found no benefit. A meta-analysis of clinical trials examining the efficacy of ketamine in treatment-resistant depression found that ketamine was more effective than placebo in reducing depressive symptoms. The review also found that the effect of ketamine on depression was quite promising.

MDMA Assisted Psychotherapy

The use of MDMA assisted psychotherapy has shown promise in the treatment of depression, particularly in treating treatment-resistant depression. Several small clinical trials have examined the efficacy of MDMA-assisted therapy in treating depression, and the results are promising. However, larger clinical trials are needed to confirm these findings.

LSD Assisted Therapy

The use of LSD-assisted therapy has also been studied as a treatment for depression. Promise has been shown, and more studies will continue in this area.

Psilocybin Assisted Therapy

The use of psilocybin-assisted therapy has shown promise in the treatment of depression, with one small study finding that it was more effective than placebo in treating treatment-resistant depression. However, larger clinical trials are needed to confirm these findings.

The use of ketamine, MDMA, LSD, and psilocybin in the treatment of depression is a relatively new area of research. More studies are needed to examine the efficacy of these substances in treating depression.

How Can I Safely Explore Alternative Treatments for Depression?

I have found that many people are interested in exploring psychedelic-assisted therapy for depression but are unsure of how to proceed. Here I will provide an introduction to some of the major psychedelics, as well as practical advice on how to safely explore these substances.

The three major psychedelics that have been studied for their potential antidepressant effects are LSD, psilocybin, and ketamine. Each of these substances has a different pharmacological profile and thus produces different effects. It is important to remember that psychedelics are powerful tools and should be used with care. Before exploring any psychedelic, it is advisable to do your research and consult with a qualified mental health professional.

1. LCD

LSD (lysergic acid diethylamide) is a semi-synthetic substance that was first synthesized in 1938. LSD is typically taken orally, although one can inhal or inject it. The effects of LSD are variable and depend on factors such as dose, set (the user’s mindset), and setting (the environment in which the drug is used). Generally, the effects of LSD last for 8-12 hours. Commonly reported effects include changes in visual perception, altered sense of time , and increased feelings of euphoria or anxiety. LSD is a non-toxic substance with a relatively low risk of overdose; however, it can produce powerful effects that may be overwhelming for some people.

2. Psilocybin

Psilocybin (4-phosphoryloxy-N, N-dimethyltryptamine) is a naturally occurring psychedelic compound found in certain types of mushrooms. It is typically consumed orally, in the form of dried mushrooms or capsules. The effects of psilocybin are similar to those of LSD; however, they tend to be shorter in duration (4-6 hours) and less intense. Psilocybin has shown an effective treatment for depression , with a single dose producing long-term antidepressant effects .

3. Ketamine

Ketamine hydrochloride is a synthetic substance that experts originally developed as an anaesthetic. Depending on the dose and how it is administered, ketamine can have various effects. At low doses, ketamine produces dissociative effects similar to those of other psychedelics. At higher doses, it can cause hallucinations and out-of-body experiences. Ketamine also has a unique ability to alleviate depression within a few hours. A single dose can provide relief for up to two weeks. It is important to note that there is no universal treatment for depression, and what works for one person may not work for another. If you have tried multiple treatments without success, you might receive a diagnosis of treatment-resistant depression. In such cases, it is crucial to consult with a mental health professional to explore alternative treatment options.

KETAMINE/ESKETAMINE FOR TREATMENT OF DEPRESSION

Depression is a mood disorder that affects millions of people worldwide, causing feelings of sadness, anxiety, and other psychological symptoms. In some cases, depression may result from mental illnesses such as schizophrenia or bipolar disorder. Today, Ketamine is a prescribed treatment option for depression provided by doctors. This drug has been effectively used for over four decades to quickly lift mood and alleviate symptoms of depression.

Overview

Ketamine, introduced in the 1960s, is an anesthetic medication with a long history of safe use in humans. It is widely regarded as one of the most effective treatments for depression. Ketamine functions by increasing the levels of serotonin and norepinephrine, two neurotransmitters known to be involved in depression. Additionally, the drug blocks NMDA receptors, which may help reduce depression symptoms.

Administration of Ketamine Therapy

Ketamine therapy is usually administered through intravenous infusion, where the medication is injected into a vein. Alternatively, it can be given intramuscularly or as a nasal spray. A typical Ketamine treatment session for depression lasts around 40 minutes, during which you will be closely monitored by your doctor or nurse to ensure both effectiveness and safety of the treatment.

Outpatient Ketamine Therapy

Generally, Ketamine therapy for depression is provided on an outpatient basis, allowing patients to return home the same day without the need for overnight hospital stays. However, in some cases, your doctor may recommend a short hospital stay to monitor your response to the medication after the treatment.

Ketamine’s Effectiveness and Use

Ketamine therapy has proven to be an effective treatment for depression that is resistant to other therapies. If you have not responded to oral antidepressants or other psychiatric medications, Ketamine therapy may be a viable option. Although Ketamine has been available for decades, its recent surge in popularity stems from its significant potential in treating chronic pain and post-traumatic stress disorder (PTSD).

Ketamine’s Role as an Anesthetic

As previously mentioned, Ketamine can also serve as an anesthetic, which contributes to its increasing popularity as an alternative treatment. Due to its ability to induce deep relaxation and euphoria, Ketamine has become one of the most sought-after drugs on the market. While some patients have reported experiencing dissociative anesthesia during ketamine injection, most patients find their treatment experiences with this medication pleasant.

Ketamine Therapy in Canada

In Canada, Ketamine therapy is not currently an approved treatment for depression. However, ongoing clinical trials are assessing its efficacy in treating this condition. If you are interested in Ketamine treatment for depression, consult your doctor to determine its suitability for you. Within Canada, private clinics offer referrals for IV ketamine infusions, although the cost to patients is generally high. Currently, IV Ketamine has not been approved as a treatment for mood disorders or chronic pain relief and is only used as an “off-label” treatment. However, in Canada, intranasal ketamine and esketamine, known as SPRAVATO, have been approved since May 2022 for the treatment of major depressive disorders.

Ketamine Therapy in the U.S.:

In the U.S., Ketamine is both FDA approved for IV infusions and intranasal sprays. It has shown improvement in both major depressive disorders and chronic pain.

Ketamine therapy is highly effective due to its different receptor binding target compared to most other antidepressants. While most antidepressants on the market today only affect serotonin or norepinephrine reuptake, Ketamine targets the glutamate neurotransmitter system. This mechanism enables its fast-acting antidepressant effects. Ketamine therapy is an increasingly popular treatment option for refractory depression, known for its generally well-tolerated nature and ability to yield rapid results. Furthermore, there is an FDA-approved oral esketamine-based antidepressant available on the market, which is often taken alongside another oral antidepressant.

Features of ketamine with antidepressant effects:

• Targets serotonin or norepinephrine re-e uptake
• Different binding target than most other antidepressants
• Can produce quick results
• Well-tolerated

Ketamine therapy has become so popular because of its different binding target abilities than most other antidepressants. It has the ability to affect the glutamate neurotransmitter system. Ketamine has an extremely fast-acting antidepressant effect. It also has the option for oral administration.

What is esketamine and how is it different from ketamine?

Eskatamine is the S-enantiomer of ketamine and is one of the two enantiomers that make up the Ketamine molecule. Esketamine has a more potent antidepressant effect than ketamine, however it also has more side effects associated with it such as dissociation and psychotomimetic effects.

Some of the side effects associated with ketamine therapy include dissociation, psychotomimetic effects, and increased blood pressure.

Some of the benefits of ketamine treatment include its ability to produce quick antidepressant effects, its well-tolerated nature, and the option for oral administration. Ketamine is considered to be one of the most promising new treatment options for depression, anxiety, and PTSD.

Other psychedelics that are being researched currently that are showing great promise in treating depression, anxiety, and PTSD – include MDMA, psilocybin, and LSD.

MDMA FOR TREATMENT REFACTORY DEPRESSION, ANXIETY, AND PTSD

It is a synthetic drug that acts as a stimulant and psychedelic. It is known for its ability to produce feelings of euphoria, empathy, and intimacy.

• Benefits associated with MDMA: Some of the potential mental health benefits associated with MDMA include its ability to reduce anxiety, depression, and PTSD symptoms. Additionally, MDMA has been shown
• Working: MDMA works by increasing the activity of serotonin, dopamine, and norepinephrine in the brain. This increase in neurotransmitter activity leads to feelings of euphoria, increased empathy, and decreased anxiety.
• Side Effects: Some of the side effects associated with MDMA include jaw clenching, nausea, dehydration, anxiety, and dizziness.

MDMA is a synthetic drug that acts as a stimulant and hallucinogen. It is thought to work by increasing levels of serotonin, dopamine, and norepinephrine in the brain. MDMA is currently illegal in most countries.

PSILOCYBIN FOR TREATMENT RESISTANT TO DEPRESSION, ANXIETY, AND PTSD

• What is it? Psilocybin is a naturally occurring psychedelic substance found in certain mushrooms. It is known for its ability to produce mystical-type experiences and hallucinations.
• What are some of the potential mental health benefits associated with psilocybin? Some of the potential mental health benefits associated with psilocybin include its antidepressant effects, as well as its ability to reduce anxiety , fear, and depression.
• What are the risks? The major risk associated with psilocybin is that it can cause psychotic episodes in vulnerable individuals. Psilocybin should also be avoided by people with a history of mental illness or substance abuse.

LSD FOR TREATMENT RESISTANT DEPRESSION, ANXIETY, AND PTSD

LSD is a potent, long-lasting psychedelic drug that can produce powerful hallucinations.

Benefits Associated With LSD: Some of the potential mental health benefits associated with LSD include its antidepressant effects and its ability to reduce anxiety levels.

Risks: The major risk associated with LSD is that it can cause psychotic episodes in vulnerable individuals. LSD should also be avoided by people with a history of mental illness or substance abuse.

OTHER TREATMENT FOR SEVERE DEPRESSIVE DISORDERS

There are many other different approaches that can be taken when dealing with major depression disorders. One of them is transcranial magnetic stimulation is a treatment that uses magnetic fields to stimulate nerve cells in the brain. This treatment is becoming more popular because it is non-invasive and has very few side effects. clinical trials have shown that transcranial magnetic stimulation can be effective in treating major depression disorders. This treatment is usually done with a device that emits magnetic pulses.

• Electroconvulsive therapy is another treatment that is sometimes used to treat major depression disorders. This therapy uses electrical stimulation to the brain and has been found to be effective in treating severe cases of depression. However, this treatment can have some side effects such as memory loss, so it is usually only used as a last resort.
• Vagus nerve stimulation (VNS) is a potential treatment to resistant depression. It is minimally invasive and has been shown to be effective in some cases. However, there are potential side effects, such as temporary confusion or memory loss.
• Deep brain stimulation (DBS) is a treatment that involves implanting electrodes into the brain. This treatment is usually only used for severe cases of depression that have not responded to other treatments. It can be effective, but there are potential risks, such as infection and stroke.

Is depression and anxiety usually cured?

The short answer is no. There are, however, treatments available that can help to manage symptoms and allow people to lead fulfilling lives. Depression is a chronic illness, which means that it can last for years or even a lifetime. However, with treatment, most people with depression will experience periods of remission (when they are free from symptoms) and recovery (when their symptoms are much less severe).

Will there be any treatment for depression in the near future?

Yes, there are always new treatments being developed and tested. However, it can take many years for a treatment to be proven effective and safe enough to be approved by the relevant authorities. What is the most effective treatment for depression?

There is no one-size-fits-all answer to this question, as different people will respond to different treatments. Some of the most commonly used treatments for depression include antidepressant medication, psychotherapy (such as cognitive behavioral therapy), and electroconvulsive therapy.

What causes treatment resistant depression?

There is no single cause of treatment to resistant depression. It is thought to be caused by a combination of factors, including genetic vulnerabilities, brain chemistry, and life experiences.

What are the qualifications for treatment resistant depression?

There is no one simple answer to this question, as different people will respond to different treatments. However, treatment-resistant depression is generally defined as depression that has not responded to two or more courses of treatment with antidepressant medication.

As an Amazon Associate, hearwegogo.com does earn from qualifying purchases.

Many people use meditation as an effective source of therapy for stress, anxiety, and depression. Shop here for a variety of audiobooks, both free and for purchase.

Diffusers with oils in all kinds of relaxing scents can achieve beneficial effects. Buy yours here.

Adult fidget tools are a great way to distract yourself when anxious or just needing to refocus. Buy yours here.

Classic Mandala Art colouring books for anxiety. Buy yours here.

Weighted blankets have also been proven to effectively improve stress, anxiety, ADHD, autism, depression, and insomnia. Buy yours here.

HELP LINES:

If ever you or anyone you know ever needs someone to listen. please call 1-833-456-4566. This line will help anyone in crisis.

You can also text 45645 anytime from 4pm-midnight ET

Kid Help Phone can be reached at www.kishelpphone.ca  or 1-800-668-6868

Canadian Suicide Prevention Service “Talk Suicide Canada” can be reached at www.talksuicide.ca or 1-833-465-4566

Naseeha Mental Helpline answers calls from around the world from Muslim and non-muslims. The can be reached at www.naseeha.org or 1-866-627-3342 or 1-866-627-3342.

Youthspace.ca offers free and confidential support and information over rext message and online chat. www.youthspace.ca or 1-788-783-0177